SLC2A4 and Alzheimer disease: Semaglutide increased the expression levels of Sirtuin1 and GLUT4 in the hippocampus of AD model mice, accompanied by an improvement in learning and memory and a decrease in Aβ plaques and neurofibrillary tangles [217].